全球電泳試劑市場規模（按產品、應用、地區、範圍和預測）

電泳試劑市場規模及預測

2021 年電泳試劑市場規模價值 12.1 億美元，預計到 2030 年將達到 25.3 億美元，2022 年至 2030 年的複合年增長率為 6.99%。推動全球電泳試劑市場大幅成長的主要因素是遺傳疾病、技術進步、傳染病和癌症的增加，以及多個地區政府對基因組學和蛋白​​質組學研究的高投入。推動全球電泳試劑市場發展的其他因素包括醫療保健基礎設施的改善、勞動成本的降低和人均收入的增加。全球電泳試劑市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

全球電泳試劑市場的定義

電泳是一種利用電荷根據 RNA、DNA 和蛋白質的片段或摩爾質量分離它們的方法。電泳技術中所使用的試劑稱為電泳試劑。醫學研究、臨床應用和生物科學都是使用該技術的行業的例子。利用電泳試劑可以診斷病毒感染和遺傳疾病。

電泳法可用於臨床研究和診斷，以改善病患照護。這種調查技術有助於識別異常蛋白質（如果存在）。它用於確定血清、血漿和尿液中不同蛋白質類別的存在。

全球電泳試劑市場概覽

遺傳疾病、技術進步、傳染病的傳播以及各國政府對基因組學和蛋白​​質組學研究的大量投入是推動全球電泳試劑市場大幅增長的關鍵因素。發展醫療保健基礎設施、低勞動成本和增加人均收入是推動全球電泳試劑市場的其他因素。

傳染病、癌症和遺傳疾病的增加促使多個國家的地方政府加大研究經費投入，生物製藥行業加大資金投入，以開發治療這些疾病的有效生物藥物。將會增加，預計預測期內將增加對電泳試劑的需求。

製藥和生物技術產業擴大採用電泳技術，推動預測期內電泳試劑市場收入的成長。隨著個人化醫療和創新藥物開發的日益重視，製藥公司正致力於利用基因組研究來建構直接依賴分子規模的藥物，這推動了電泳試劑市場的銷售成長。

對傳染病、癌症和遺傳問題的研究不斷增加，推動了世界各地地方政府的資金投入，用於開發治療這些疾病的有效生物藥物，而這些藥物供應不足。捐款。凝膠電泳測試耗時、測試程序有限以及可提高效率和結果的替代技術的可用性限制了市場的成長。

然而，缺乏技術知識和試劑產量減少可能最終導致產品召回並阻礙電泳試劑市場的發展。預測期內，人均收入水準提高和消費者醫療保健支出增加等因素也有望推動電泳試劑產業的發展。然而，電泳試劑市場的擴大可能會受到技術知識不足和試劑製造品質低落的限制，最終導致產品退貨。

目錄

第 1 章全球電泳試劑市場簡介

市場概況
• 研究範圍
• 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

• 資料探勘
• 驗證
• 主要來源
• 資料來源列表

第4章 電泳試劑全球市場展望

• 概述
• 市場動態
• 驅動程式
• 阻礙因素
• 機會
• 波特五力模型
• 價值鏈分析

第5章 全球電泳試劑市場（依產品劃分）

• 凝膠
• 染料
• 緩衝區
• 其他電泳試劑

第6章全球電泳試劑市場（依應用）

蛋白質分析 DNA 和 RNA 分析

第7章 全球電泳試劑市場（按地區）

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 德國
• 英國
• 法國
• 其他歐洲國家 亞太地區
• 中國
• 日本
• 印度
• 其他亞太地區
• 世界其他地區
• 拉丁美洲
• 中東和非洲

第 8 章全球電泳試藥市場：競爭格局

• 概述
• 各公司的市場排名
• 主要發展策略

第9章 公司簡介

• Thermo Fisher Scientific
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Merck Millipore
• GE Healthcare
• Agilent Technologies, Inc.
• Lonza Group, AG
• Takara Bio, Inc.
• Harvard Bioscience, Inc.
• Sebia Group

第 10 章附錄

• 相關報告

Electrophoresis Reagents Market Size And Forecast

Electrophoresis Reagents Market size was valued at USD 1.21 Billion in 2021 and is projected to reach USD 2.53 Billion by 2030, growing at a CAGR of 6.99% from 2022 to 2030. The major factors accountable for the significant growth in the Global Electrophoresis Reagents Market are owing to the rise in genetic disorders, technological advancements, infectious diseases, and cancer, and high investments by governments in genomics and proteomics research in several regions. The other factors accountable for the Global Electrophoresis Reagents Market are improvements in healthcare infrastructure, low labor costs, and growing per capita income. The Global Electrophoresis Reagents Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electrophoresis Reagents Market Definition

Electrophoresis is a method that is used to separate RNA, DNA, and protein based on fragments or molar mass using an electrical charge. The reagents used in the electrophoresis technique are known as electrophoresis reagents. Medical studies, clinical applications, and biosciences are all instances of industries that apply the approach. Viral infections and genetic disorders can be diagnosed using electrophoresis reagents.

It is applied in clinical research and clinical diagnostics to improve patient treatment. The methodology helps in the identification of aberrant proteins that are made up if any exist. It's used to check the presence of different protein classes in serum, plasma, as well as urine.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Electrophoresis Reagents Market Overview

The expansion in genetic disorders, technological advancements, and contagious diseases, as well as significant government expenditure in genomics and proteomics research in a variety of countries, are the important components contributing to the significant growth in the Global Electrophoresis Reagents Market. Developments in healthcare infrastructure, low labor costs, and rising per capita revenue are among the other factors driving for worldwide Electrophoresis Reagents Market.

Growing rates of contagious diseases, cancer, and genetic problems are anticipated to enhance funding for research from local authorities in several countries, and also private money from biopharmaceutical companies, for the creation of efficient biologics for trying to treat these diseases, which is anticipated to enhance the requirement for electrophoresis reagents over the forecast.

Over the projected time frame, the rising adoption of electrophoresis techniques in the pharmaceutical and biotechnology businesses is responsible for driving sales increases in the Electrophoresis Reagents Market. With the increasing emphasis on personalized medicine and innovative pharmaceutical development, pharmaceutical companies are focusing on building pharmaceuticals that directly depend on the molecular scale utilizing genomic investigations, which is expected to drive revenue growth in the Electrophoresis Reagents Marketplace.

Rising interest rates for infectious diseases, cancer, and genetic problems are projected to increase funding for research from local governments worldwide, as well as private donations from pharmaceutical companies, for the development of effective biologic drugs to cure these diseases, which is missing. Time-consuming techniques and limiting testing procedures via gel electrophoresis, and also the availability of substitute techniques that provide improved efficiencies and results, are restricting the market's growth.

However, a lack of technical knowledge and reduced reagent production, which finally leads to product recalls, may impede the Electrophoresis Reagents Market development. Over the projection timeframe, factors including increasing per-income levels and increased customer healthcare expenditure are also expected to boost the electrophoresis reagents industry. However, the Electrophoresis Reagents Market's expansion may be limited by inadequate technical knowledge and the manufacturing of low-quality reagents, which eventually lead to product returns.

Global Electrophoresis Reagents Market: Segmentation Analysis

The Global Electrophoresis Reagents Market is Segmented on the basis of Product, Application, And Geography.

Electrophoresis Reagents Market, By Product

• Gels
• Dyes
• Buffers
• Other Electrophoresis Reagents

Based on Product, the market is segmented into Gels, Dyes, Buffers, and Other Electrophoresis Reagents. Due to the increasing use of gels in protein determination and DNA & RNA analysis, the gel segment accounted for the largest share of the Global Electrophoresis Reagents Market in 2021.

Electrophoresis Reagents Market, By Application

• Protein Analysis
• DNA & RNA Analysis

Based on Application, the market is segmented into Protein Analysis and DNA & RNA Analysis. This market has been dominated by the protein analysis sector in the year 2021. This is mainly attributed to the rising focus of pharmaceutical and biotechnology on the proteomic study.

Electrophoresis Reagents Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Electrophoresis Reagents Market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. North America held the largest market share in 2021 and is expected to continue its dominance over the forecast period. The growth of the market for electrophoresis reagents in the North American segment can be attributed to a rising number of proteomic and genotyping research studies in Canada and the United States. In addition, increasingly stringent regulatory prerequisites for the pharma industry across the region further drive the growth of the market.

Key Players

• The "Global Electrophoresis Reagents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck Millipore, GE Healthcare, Agilent Technologies, Inc., Lonza Group, AG, Takara Bio, Inc., Harvard Bioscience, Inc., Sebia Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Merck Millipore (US) finalized its acquisition of Sigma-Aldrich in 2015. (U.S.)
• Agilent Technologies Inc. (USA) purchased Seahorse Bioscience in 2015. (U.S.).
• The IH-500, a completely automated random access system for blood type and screening, was introduced by Bio-Rad Laboratories, Inc. (US) in 2015.
• Agilent Technologies Inc. (US) released new SurePrint gene expression microarrays for messenger RNA profiling applications in human, mouse, and rat models in 2015.
• Thermo Fisher Scientific (US) launched a new GMP Clinical Services Facility in Singapore in 2015. The company's supply capabilities in the Asia-Pacific market were bolstered by this new plant.

TABLE OF CONTENTS

1. Introduction of Global Electrophoresis Reagents Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Electrophoresis Reagents Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Electrophoresis Reagents Market, By Product

• Gels
• Dyes
• Buffers
• Other Electrophoresis Reagents

6. Global Electrophoresis Reagents Market, By Application

• Protein Analysis
• DNA & RNA Analysis

7. Global Electrophoresis Reagents Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Electrophoresis Reagents Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Thermo Fisher Scientific
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Merck Millipore
• GE Healthcare
• Agilent Technologies, Inc.
• Lonza Group, AG
• Takara Bio, Inc.
• Harvard Bioscience, Inc.
• Sebia Group

10. Appendix

• Related Reports